BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30383904)

  • 21. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
    Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
    Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour.
    Tsang JY; Ni YB; Ng EK; Shin VY; Mak KF; Go EM; Tawasil J; Chan SK; Ko CW; Kwong A; Tse GM
    Histopathology; 2015 Sep; 67(3):294-305. PubMed ID: 25585495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
    Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
    J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
    Takizawa K; Yamamoto H; Taguchi K; Ohno S; Tokunaga E; Yamashita N; Kubo M; Nakamura M; Oda Y
    Hum Pathol; 2016 Sep; 55():30-8. PubMed ID: 27137988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
    Kocová L; Skálová A; Fakan F; Rousarová M
    Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.
    Wang J; Zhang C; Chen K; Tang H; Tang J; Song C; Xie X
    Breast Cancer Res Treat; 2015 Jul; 152(2):255-69. PubMed ID: 26070269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
    Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
    Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
    Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
    Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
    J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
    Tan WJ; Lai JC; Thike AA; Lim JC; Tan SY; Koh VC; Lim TH; Bay BH; Tan MH; Tan PH
    Breast Cancer Res Treat; 2014 Jun; 145(3):635-45. PubMed ID: 24831776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study.
    Borhani-Khomani K; Talman ML; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2016 May; 23(5):1543-8. PubMed ID: 26714948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
    Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
    PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    Cha YJ; Koo JS
    PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours.
    Karim RZ; Gerega SK; Yang YH; Horvath L; Spillane A; Carmalt H; Scolyer RA; Lee CS
    J Clin Pathol; 2009 Nov; 62(11):1016-20. PubMed ID: 19861560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive and prognostic significance of p27, Akt, PTEN and PI3K expression in HER2-positive metastatic breast cancer.
    Okutur K; Bassulu N; Dalar L; Aydin K; Bozkurt M; Pilanci KN; Dogusoy GB; Tecimer C; Mandel NM; Demir G
    Asian Pac J Cancer Prev; 2015; 16(7):2645-51. PubMed ID: 25854340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.